Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Pulmonary Embolism · Carcinoma, Hepatocellular

Bayer HealthCare Animal

Bayer HealthCare AG

Bayer HealthCare Animal trial registry — 35 ClinicalTrials.gov studies with program phase, status, and indication context.

Website
3915 S 48TH STREET TER, St. Joseph, Missouri 64503, us HQ
1919 Founded
8 Employees
EMA registrant Type
Company details
Status
Public
HQ
3915 S 48TH STREET TER, St. Joseph, Missouri 64503, us
Founded
1919
Employees
8
Programs
34
Drugs
32
Patents
24
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Bayer HealthCare Animal clinical trials

Registry index of 35 ClinicalTrials.gov studies linked to Bayer HealthCare Animal programs — each row shows trial ID, program name, phase, status, and indication.

Bayer HealthCare Animal trial registry — 35 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Bayer HealthCare Animal.

  1. 91396 — Phase 2

    Clinical update

  2. 91782 — Phase 3

    Clinical update

  3. 91774 — Phase 3

    Clinical update

  4. 91781 — Phase 3

    Clinical update

  5. 15161 — Phase 3

    Clinical update

  6. Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin — Phase 2

    Clinical update

  7. Sorafenib (Nexavar, BAY43-9006) — Phase 3

    Clinical update

  8. Sorafenib (Nexavar, BAY43-9006) — Phase 3

    Clinical update

Trial registry

35 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.